Aktana

Aktana specializes in providing data and intelligence solutions for life sciences industries. Aktana offers the "Contextual Intelligence 360," a modular sales intelligence platform, to scale AI-driven programs that personalize the customer engagement process for life science commercial teams. Its contextual intelligence engine (CIE) uses machine learning (ML) algorithms to plan and arrange multichannel interactions with healthcare providers (HCPs). The platform also features personalized next-best-action recommendations, customer journey mapping tools, automated workflows, a template library, and analytics and reporting. Additionally, it has native integration with customer relationship management (CRM) and marketing automation platforms (MAP) as well as an API for custom integration.

The company claims that its solutions improved sales growth by 14% during the indication launch for an innovative oncology drug and a 10% increase in goal attainment for primary care representatives carrying multiple products.

In October 2021, The company acquired Ople.AI, a predictive analytics platform, to increase the use and adoption of AI, particularly among developing or mid-market businesses. In November 2023, Aktana acquired Tact.ai, a field engagement and conversational AI platform, to further strengthen its solution.

Key customers and partnerships

By December 2022, it had served 700,000 users across 300+ brands, including over half of the top 20 pharmaceutical firms in the world, such as Pfizer, Janssen, Merck, and Novartis.

In September 2022, the company entered into a strategic partnership with Envision Pharma Group, a comprehensive global medical communications group, to provide personalized solutions that blend Envision's scientific expertise and Aktana's intelligence platform for medical affairs teams.